Lurbinectedin (L) combined with paclitaxel (P) or irinotecan (I) in relapsed SCLC. Results from two phase Lb trials Meeting Abstract
| Authors: | Ponce, S.; Calvo, E.; De Miguel, M. J.; Sessa, C.; Flor, M. J.; Drilon, A.; Falcon, A.; Sanchez Simon, I.; Nuñez, R.; Luepke, X. E.; Cuevas-Melendez, N.; Lopez-Vilarino, J.; Fudio, S.; Siguero, M.; Cullell-Young, M.; Kahatt, C.; Zeaiter, A.; Paz-Ares, L. |
| Abstract Title: | Lurbinectedin (L) combined with paclitaxel (P) or irinotecan (I) in relapsed SCLC. Results from two phase Lb trials |
| Meeting Title: | 20th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC) |
| Keywords: | combination; sclc; lurbinectedin |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 14 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2019 Sept 7-10 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-10-01 |
| Start Page: | S817 |
| Language: | English |
| ACCESSION: | WOS:000492162204243 |
| DOI: | 10.1016/j.jtho.2019.08.1758 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P2.12-13 -- Source: Wos |
